Lucira Health, Inc. (LHDX) Stock Analysis
DELISTED 2023
What happened to Lucira Health, Inc. (LHDX) stock?
Lucira Health, Inc. (LHDX) no longer trades on public markets. It was delisted in March 2023. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
- Delisting date:
- March 2023
- Last recorded price (historical):
- $0.4523 (last quote on record before the March 2023 delisting; historical, not a current quote)
Market cap $18.4M is the value of all shares combined.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Lucira Health, Inc. (LHDX). Lucira Health, Inc. develops and commercializes diagnostic test kits for infectious diseases, leveraging a molecular testing platform. Its primary product is the LUCIRA COVID-19 All-In-One Test Kit, with development underway for influenza A and B diagnostics.
Last analyzed: Jun 15, 2026Lucira Health, Inc. (LHDX) Healthcare & Pipeline Overview
More about this archive record
Can I still buy LHDX shares?
No. LHDX stopped trading on public markets in March 2023, so the shares are not available through a broker. Anything you see quoted for LHDX elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before LHDX stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Lucira Health, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.